Latest Botanix Pharmaceuticals (ASX:BOT) News
Page 2
Page 2 of 3
Botanix Boosts Sofdra Sales 171% but Posts $33M Half-Year Loss
27 Feb 2026
Market Wrap - Week 8 (16 Feb -> 20 Feb) 2026
21 Feb 2026
Healthcare Wrap - Week 8 (16 Feb -> 20 Feb) 2026
21 Feb 2026
Botanix Pharmaceuticals Raises A$45 Million to Fuel Sofdra® Growth and Cut API Costs
17 Feb 2026
Botanix Raises A$45 Million to Secure Supply Chain and Boost Sofdra Growth
17 Feb 2026
Healthcare Wrap - Week 5 (26 Jan -> 30 Jan) 2026
31 Jan 2026
Botanix Sofdra Sales Surge 28% Amid Strategic Sales Force Expansion
27 Jan 2026
Botanix Boosts Sofdra Sales 50% with Expanded US Sales Force
20 Oct 2025
Botanix’s ECCLOCK® Gel Gains South Korean Approval, Launch Set for 2026
5 Sept 2025
Botanix Reports $5.76M Revenue Amid $86.4M Loss as Sofdra Launch Accelerates
29 Aug 2025
Botanix Clarifies $25M Sales Surge and ASX Disclosure Timing
31 July 2025
Botanix’s Sofdra Sales Surge Fuels $40M Capital Raise and $30M Debt Facility
28 July 2025